Tracking the next pandemic: Avian Flu Talk |
Canada largest drug stockpile/still short |
Post Reply |
Author | |
Guests
Guest Group |
Post Options
Thanks(0)
Posted: February 04 2006 at 6:27pm |
Flu drug shortage has wide-ranging impact
GLORIA GALLOWAY From Saturday's Globe and Mail OTTAWA — Doctors, nurses and other emergency workers are unlikely to receive preventive doses of a drug that is predicted to be the best defence against infection during an influenza pandemic because the existing stock will be needed to treat the seriously ill. This is the reality, officials say, despite the fact that Canada's pandemic influenza plan states that antiviral drugs, in particularly oseltamivir (marketed as Tamiflu), could be used as a "prophylactic" to prevent or reduce the severity of the disease among people essential to keeping society functioning. These include firefighters, police, elected officials, funeral directors, utility workers and even truck drivers who transport food and medicine. "Prophylaxis of this group will minimize societal disruption," the plan says. And some public-service sectors are building their own pandemic preparations around the assumption the drug will be available to at least some of their essential personnel -- even though its effectiveness is something of a question mark. Given the recommended course of 10 pills over five days for each infected person, the existing stockpile of 35 million tablets is unlikely to be enough to treat the estimated 4.5 million to 10.6 million Canadians predicted to fall ill should a flu pandemic occur. And even the front-line medical workers -- who are further up the priority list than those responsible for keeping the peace, feeding and heating the country, and burying the dead -- would not likely get access to Tamiflu until they themselves fell ill. The plan estimates that if a flu pandemic hit, between 15 per cent and 35 per cent of Canadians would become so ill that they would be at least temporarily debilitated; it also estimates that as many as 58,000 would die. To be effective in reducing the severity of the disease, Tamiflu must be administered within two days after its onset, but not all of the infected would get treatment in that time period. "If we wanted to stockpile for 35 per cent, we don't have enough, and we're continuing to work on what the actual numbers should be and calculating the resources that would be required to add to the reserve," said Dr. Paul Gully, a deputy chief public health officer at the Public Health Agency of Canada. And "if we wanted to use antivirals for prophylaxes of health-care workers in direct contact with sick individuals . . . again, we would not have sufficient" amounts. Canada has the largest per capita stockpile of the drug of any country in the world. But its maker, F. Hoffman La Roche Ltd., has the annual capacity to produce enough of the drug to treat 300 million people. Given the number of countries clamouring for it, it is extremely short supply. So if a pandemic were to hit, it is clear that there would not be enough of the drug to go around. "Obviously the main aim is to get a vaccine. That has always been the pillar," Dr. Gully said. But a vaccine could take some time to develop. "Antivirals would fill in the gap before we had a vaccine," he said. "Having said that, we want to tell people that there are other things they can do to protect themselves and to protect others if they are in fact sick." Those include simple measures such as hand washing and staying home when one feels sick. Dr. Ruth Collins-Nakai, president of the Canadian Medical Association, said large numbers of health-care workers would fall sick during a pandemic. And there is no "surge capacity" in the system to accommodate the loss of those doctors and nurses at a time when so many more people would be seriously ill, she said. "I don't think anybody should be counting on antivirals," Dr. Collins-Nakai said. Not only is there a limited supply, "the influenza virus mutates sufficiently fast enough that, by the time we're in the middle of the pandemic, the virus is likely to have developed a resistance." So she too is counting on the rapid development of a vaccine. A prophylactic like Tamiflu would be helpful for the first few cases, she said. "But the trick is going to be [building> flexibility into the system and the communication between front-line workers and the people making decisions, so you can change the strategy as you get information from the ground," Dr. Collins-Nakai said. http://www.theglobeandmail.com/servlet/story/RTGAM. 20060204.wxtamiflu04/BNStory/specialScienceandHealth/home |
|
Post Reply | |
Tweet
|
Forum Jump | Forum Permissions You cannot post new topics in this forum You cannot reply to topics in this forum You cannot delete your posts in this forum You cannot edit your posts in this forum You cannot create polls in this forum You can vote in polls in this forum |